Latest Regulatory Filings News

Page 8 of 54
Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.
Ada Torres
Ada Torres
17 Feb 2026
Kali Metals Limited has successfully raised approximately A$7 million through a Tranche 1 Placement, issuing over 38 million new shares at 18 cents each. This capital injection marks a significant step in the company’s funding strategy.
Maxwell Dee
Maxwell Dee
17 Feb 2026
Native Mineral Resources has successfully poured 1,543 ounces of gold doré at its Blackjack Processing Plant, while progressing key operational and regulatory initiatives to optimise mining and processing activities.
Maxwell Dee
Maxwell Dee
17 Feb 2026
Bubalus Resources has responded to ASX concerns over a delayed director interest notice, attributing the lapse to an administrative oversight and reaffirming its commitment to compliance.
Maxwell Dee
Maxwell Dee
13 Feb 2026
Patrys Limited has appointed Dr Samantha South as its new CEO, aiming to leverage her biotech expertise to fast-track clinical development and commercialisation of its therapeutic antibody pipeline.
Ada Torres
Ada Torres
12 Feb 2026
Algorae Pharmaceuticals has secured a key Licence & Supply Agreement with Cadila Pharmaceuticals to commercialise two generic cardiovascular and metabolic medicines in Australia and New Zealand, broadening its therapeutic reach beyond oncology.
Victor Sage
Victor Sage
9 Feb 2026
Bridge SaaS Limited has issued a correction to its Appendix 4C quarterly cash flow report, clarifying previously omitted financing facilities without affecting its cash position or operating results.
Sophie Babbage
Sophie Babbage
6 Feb 2026
Memphasys has raised $800,000 through a share placement to accelerate the commercial expansion of its Felix™ System, following key regulatory approvals and initial revenue milestones.
Ada Torres
Ada Torres
6 Feb 2026
Imricor Medical Systems has taken a significant step toward US market entry by submitting its Advantage-MR EP Recorder/Stimulator system for FDA 510(k) clearance, aiming to enhance MRI-guided cardiac procedures.
Ada Torres
Ada Torres
6 Feb 2026
Native Mineral Resources’ board members have converted $1.62 million in options into 63 million new shares, reinforcing their commitment to the company’s growth strategy and key projects in northern Queensland.
Maxwell Dee
Maxwell Dee
6 Feb 2026
WRKR Ltd has completed its strategic acquisition of PaidRight Holdings, issuing over 90 million shares to expand its compliance platform into payroll compliance. This move marks a significant step beyond superannuation, aiming to create a comprehensive compliance solution.
Sophie Babbage
Sophie Babbage
5 Feb 2026
Livium Ltd announces a further A$335,000 distribution from its 50% stake in the LieNA joint venture, following receipt of a substantial R&D tax incentive rebate for FY25. The joint venture remains well-funded through FY27, supporting ongoing lithium extraction technology development.
Maxwell Dee
Maxwell Dee
4 Feb 2026